On T2* Magnetic Resonance and Cardiac Iron
Top Cited Papers
Open Access
- 12 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (14) , 1519-1528
- https://doi.org/10.1161/circulationaha.110.007641
Abstract
Background—: Measurement of myocardial iron is key to the clinical management of patients at risk of siderotic cardiomyopathy. The cardiovascular magnetic resonance relaxation parameter R2* (assessed clinically via its reciprocal, T2*) measured in the ventricular septum is used to assess cardiac iron, but iron calibration and distribution data in humans are limited. Methods and Results—: Twelve human hearts were studied from transfusion-dependent patients after either death (heart failure, n=7; stroke, n=1) or transplantation for end-stage heart failure (n=4). After cardiovascular magnetic resonance R2* measurement, tissue iron concentration was measured in multiple samples of each heart with inductively coupled plasma atomic emission spectroscopy. Iron distribution throughout the heart showed no systematic variation between segments, but epicardial iron concentration was higher than in the endocardium. The mean±SD global myocardial iron causing severe heart failure in 10 patients was 5.98±2.42 mg/g dry weight (range, 3.19 to 9.50 mg/g), but in 1 outlier case of heart failure was 25.9 mg/g dry weight. Myocardial ln[R2*] was strongly linearly correlated with ln[Fe] ( R 2 =0.910, P −1.22 for the clinical calibration equation with [Fe] in milligrams per gram dry weight and T2* in milliseconds. Midventricular septal iron concentration and R2* were both highly representative of mean global myocardial iron. Conclusions—: These data detail the iron distribution throughout the heart in iron overload and provide calibration in humans for cardiovascular magnetic resonance R2* against myocardial iron concentration. The iron values are of considerable interest in terms of the level of cardiac iron associated with iron-related death and indicate that the heart is more sensitive to iron loading than the liver. The results also validate the current clinical practice of monitoring cardiac iron in vivo by cardiovascular magnetic resonance of the midseptum.Keywords
This publication has 38 references indexed in Scilit:
- International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centersJournal of Magnetic Resonance Imaging, 2010
- Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaMagnetic Resonance Imaging, 2010
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia MajorCirculation, 2009
- Relationship of Magnetic Resonance Imaging Estimation of Myocardial Iron to Left Ventricular Systolic and Diastolic Function in ThalassemiaJACC: Cardiovascular Imaging, 2008
- Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2008
- MRI detects myocardial iron in the human heartMagnetic Resonance in Medicine, 2006
- A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β‐thalassemia majorEuropean Journal of Haematology, 2005
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- Histochemical Studies of the Myocardium and Conduction System in Acquired Iron-Storage DiseaseCirculation, 1967
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964